Summary - A new market study, titled “Global Biodefense Market Research Report 2020”has been featured on WiseGuy Reports.
Global biodefense market will reach $15.85 billion by 2030, growing by 6.2% annually over 2020-2030 owing to the rising need for military and civilian vaccines and equipment against diseases including COVID-19 pandemic.
Highlighted with 84 tables and 73 figures, this 165-page report “Global Biodefense Market 2020-2030 by Product (Vaccines, Detection Devices, Antibiotics, Masks), Sales Channel, Application (Military, Civilian), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global biodefense market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2015-2019 and provides forecast from 2020 till 2030 with 2019 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global biodefense market in every aspect of the classification from perspectives of Product, Sales Channel, Application, and Region.
Based on Product, the global market is segmented into the following sub-markets with annual revenue for 2019-2030 included in each section.
Key Players (this may not be a complete list and extra companies can be added upon request):
Achaogen, Inc.
Alexeter Technologies LLC
Alnylam Pharmaceuticals, Inc.
Altimmune, Inc.
Bavarian Nordic AS
BioFactura, Inc.
Cleveland Biolabs, Inc.
Dynavax Technologies Inc
Dynport Vaccine Company LLC (DVC)
Elusys Therapeutics, Inc.
Emergent BioSolutions Inc
General Dynamics Corp.
GlaxoSmithKline Plc
Ichor Medical Systems
Mediimmune (AstraZeneca)
Nanotherapeutics, Inc.
Ology Bioscience
PathSensors Inc
Pluristem Therapeutics
Sanofi Pasteur Ltd.
SIGA Technologies, Inc.
Soligenix, Inc.
Xoma Corporation
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
FOR MORE DETAILS: https://www.wiseguyreports.com/reports/5526771-global-biodefense-market-2020-2030-by-product-vaccines
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +162-825-80070 (US)
Ph: +44 203 500 2763 (UK)
Global Biodefense market is valued at USD 5.31 Billion in 2018 and expected to reach USD 7.22 Billion by 2025 with the CAGR of 4.5 %over the forecast period.Favorable government initiatives, Increase in the number of naturally occurring outbreaks, and increasing threat of biological weapons and nuclear armed ICBM are some of the major factors driving the growth of global biodefense marketBiodefense constitutes the use of medical measures to protect individuals against bioterrorism including interventions such as drugs and vaccinations but also research and public health preparations to defend against such biological attack.
The goal of biodefense is to integrate the sustained efforts of the national and homeland security, medical, public health, intelligence, diplomatic, and law enforcement communities.
Biodefense is an emerging industry that offers new opportunities for both existing and new drug companies, as well as for biotechnology companies with technologies for drug discovery and pathogen detection.Get Sample Copy of This Premium Report: @ https://industrystatsreport.com/Request/Sample?ResearchPostId=12902=SampleGlobal biodefense market report is segmented on the basis of product type, application and regional& country level.
On the basis of country level, market of Biodefense is sub divided into U.S., Mexico, Canada, UK, France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.Biodefense CompaniesElusys Therapeutics, Inc.Emergent BioSolutions, Inc.DynPort Vaccine Company, LLCSIGA TechnologiesPharmAthene, Inc.Cleveland BioLabsIchor Medical SystemsAchaogen, Inc.Xoma CorporationDynavax Technologies CorporationBavarian Nordic others.Favorable government initiatives, increase in the number of naturally occurring outbreaks, and increasing threat of biological weapons and nuclear armed ICBM are some of the major factors driving the growth of global biodefense market.Favorable government initiatives, increase in the number of naturally occurring outbreaks, and increasing threat of biological weapons and nuclear armed ICBM are some of the major factors driving the growth of global biodefense market.
For instance, Centers for Disease Control and Prevention estimates, between 2016 and 2017, nearly 30 Million people suffered from influenza in the country.
For instance, according to the World Health Organization, More than 28,000 people were infected, and over 11,000 people died before the international public health emergency ended in June 2016.
